CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies resistant to current chemotherapies or radiotherapies, which makes it urgent to identify new therapeutic targets for HCC. In this study, we found that checkpoint kinase 1 (CHK1) was frequently overexpressed and correlated with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hong, Jian, Hu, Kaishun, Yuan, Yunfei, Sang, Yi, Bu, Qiangui, Chen, Guihua, Yang, Longjun, Li, Binkui, Huang, Pinzhu, Chen, Dongtai, Liang, Yi, Zhang, Ruhua, Pan, Jingxuan, Zeng, Yi-Xin, Kang, Tiebang
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3589177/
https://ncbi.nlm.nih.gov/pubmed/22585575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI61380
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados